Rahul Patil
Research Subjects
Rahul Patil has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Amarkumar Dhirajlal Rajgor
Department of Otorhinolaryngology, Freeman Hospital, Newcastle upon Tyne, UK; National Institute For Health & Care Research, Doctoral Fellow, Population Health Sciences Institute, Newcastle University, UK
2 shared publications - Muhammad Shahid Iqbal
Northern Centre for Cancer Care, Newcastle upon Tyne, UK; Honorary Senior Clinical Lecturer, Newcastle University, Newcastle upon Tyne, UK
2 shared publications Charles Kelly
Northern Centre for Cancer Care Newcastle upon Tyne UK
1 shared publication- Charles Kelly
Northern Centre for Cancer Care, Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN United Kingdom
1 shared publication - J. Adams
Department of Oral and Maxillofacial Surgery, Royal Victoria Hospital, Newcastle upon Tyne, UK
1 shared publication Jakub Cvek
Department of Oncology University of Ostrava Ostrava Czech Republic
1 shared publication
Latest Publications
- 18 June 2026
- Published by Wiley in Head & Neck
- Vol. 48 (12) , 3320-3328
Impact of Soft Palate Involvement on the Outcome of Definitive (Chemo)radiotherapy for Tonsillar Squamous Cell Carcinoma
Background: To analyze the impact of soft palate involvement on survival outcomes of patients with tonsillar carcinoma treated with definitive (chemo)radiotherapy. Methods: A total of 402 patients treated between January 2010 and December 2023 were included. Results: Soft palate was involved in 170 patients. A complete response was achieved in 381 patients. Locoregional recurrence occurred in 26 patients (6.5%) and distant metastasis in 56 patients (13.9%). For the whole group, the 5‐year rates for local control, disease‐free survival, disease‐specific survival, and overall survival were 92.6%, 74.6%, 80.6%, and 74.8%, respectively. Smoking status, nodal stage, systemic treatment and soft palate involvement were identified as prognostic factors. The rate of distant metastasis was significantly higher in patients with soft palate involvement (19.4% vs. 9.9%; p = 0.0066). Conclusion: To the best of authors' knowledge, we report the first study to analyze the impact of soft palate involvement on outcomes for patients with tonsillar cancer treated with (chemo)radiotherapy. The incidence of local recurrence is low; however, the rate of distant metastasis is high and is significantly higher in patients with soft palate involvement.
- 18 June 2026
- Published by Wiley in Head & Neck
- Vol. 48 (12) , 3320-3328
Impact of Soft Palate Involvement on the Outcome of Definitive (Chemo)radiotherapy for Tonsillar Squamous Cell Carcinoma
Background: To analyze the impact of soft palate involvement on survival outcomes of patients with tonsillar carcinoma treated with definitive (chemo)radiotherapy. Methods: A total of 402 patients treated between January 2010 and December 2023 were included. Results: Soft palate was involved in 170 patients. A complete response was achieved in 381 patients. Locoregional recurrence occurred in 26 patients (6.5%) and distant metastasis in 56 patients (13.9%). For the whole group, the 5‐year rates for local control, disease‐free survival, disease‐specific survival, and overall survival were 92.6%, 74.6%, 80.6%, and 74.8%, respectively. Smoking status, nodal stage, systemic treatment and soft palate involvement were identified as prognostic factors. The rate of distant metastasis was significantly higher in patients with soft palate involvement (19.4% vs. 9.9%; p = 0.0066). Conclusion: To the best of authors' knowledge, we report the first study to analyze the impact of soft palate involvement on outcomes for patients with tonsillar cancer treated with (chemo)radiotherapy. The incidence of local recurrence is low; however, the rate of distant metastasis is high and is significantly higher in patients with soft palate involvement.
- 24 January 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104064
High Incidence of Mandibular Osteoradionecrosis After Radiotherapy for Oral Cavity: Time for Rebalancing Risks and Benefits
- 24 January 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104064
High Incidence of Mandibular Osteoradionecrosis After Radiotherapy for Oral Cavity: Time for Rebalancing Risks and Benefits